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time. 
Conclusions: SD for Δ was <1.5 mm in all directions, suggesting 
relatively good stability in the time-averaged position of these mobile 
targets. Delivery times were short and no correlation was observed 
between Δ and time. The results support frameless, free-breathing, 
lung SBRT performed with FFF RapidArc.  
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Purpose/Objective: Stereotactic irradiation of pancreatic cancers is 
hampered by respiratory movements of the tumor. An ITV that 
encloses the peak-to-peak breathing amplitude yields large PTVs and, 
therefore, may potentially harm nearby organs at risk. Gated delivery 
enables ITV reduction. However, this will increase treatment time as 
the radiation beam periodically is switched on and off. The aim of this 
work is to assess pancreatic tumor motion in order to find a patient 
specific optimal tradeoff between duty cycle and ITV. 
Materials and Methods: 12 pancreatic cancer patients were imaged 
for a minute using cine-MRI on a 1.5T scanner. Sagittal and coronal 
scans, located through the center of the tumor, were acquired using a 
mixed T1/T2 weighted sequence (bSSFP) at a rate of two frames per 
second and a slice thickness of 7mm (fig 1A). Tumor tracking was 
performed with a Minimum Output Sum of Squared Error (MOSSE) 
adaptive correlation filter, which enables real-time tracking of a 
moving object. 
Results: The greatest pancreatic tumor motion was found in cranio-
caudal direction (mean 24mm, SD 13mm, range 10-49mm). The end-
exhale position (EEP) was consistently reproduced (1SD=1.1mm, over 
all patients) whereas the end-inhale position (EIP) was less consistent 
(1SD=2.3mm, over all patients) (fig 1B). Further analysis also revealed 
that the tumors spend more time close to the EEP than to the EIP 
(average EIP/EEP ratio = 0.70, range 0.62-0.85). Both findings support 
the preference of gating around the EEP. At free breathing conditions, 
the entire breathing amplitude needs to be added to the ‘static’ CTV 
at EEP to build the ITV. However, this margin decreases dramatically - 
to a quarter of the amplitude (range 13%-40%) – when a gating duty 
cycle of 50% is used (beam on time = beam off time) (fig 1C). 
 
  
Conclusions: Gated delivery for stereotactic radiotherapy of 
pancreatic cancer is best performed around the end-exhale position. 
Considerable CTV-to-ITV margin reduction can be established at 
moderate gating windows, yielding acceptable treatment efficiency. A 
semi-automated method was developed to optimize gating window for 
individual patients. 
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Purpose/Objective: Cranial stereotactic radiosurgery treatment could 
today be delivering by different arctherapy techniques. In order to 
select the best one according to the number and the position of the 
lesions we compare in this study dynamic conformal arc, coplanar 
VMAT and noncoplanar VMAT. 
Materials and Methods: Patients with single lesion (n=5), multiple 
lesions (n=5) and single lesion close to organs at risk (n=4) and 
previously treated with dynamic conformal arc (DCA) were selected 
for this analysis. For each patient, two additional plans were 
generated using 2 coplanar arc VMAT (RAC) and noncoplanar arc VMAT 
(RANC). For single lesions, the ballistic for RANC is the same as for DCA 
(3-4 arcs per lesion). In multiple lesions case, only 4 noncoplanar arcs 
were used with a single isocenter compare with a multiple isocenter 
treatment for DCA. All plans were evaluated in regard to conformity 
and homogeneity indexes for PTV (CI= (PTV covered by prescription 
isodose)²/VPTV*VPresciption isodose and I=(Dmax-Dmin)/Dmean ), the healthy brain 
tissue dose (goal V10Gy < 12,5cc) , the dose to organs at risk and the 
number of monitor units (MU). 
Results: Concerning single lesion, the HI and the CI were better RANC 
but DCA improved healthy brain protection and treatment delivery 
time even if global room occupation is higher. For multiple lesions, 
VMAT techniques provided similar homogeneity and conformity 
degrees. The healthy brain was as well protected with DCA as with 
RANC. If we look the MU numbers, RAC <RANC < DCA. For single lesion 
close to OAR, the HI was similar for VMAT techniques but RAC 
improved the protection of healthy brain and organs at risk. On the 
other hand, the delivery treatment time is shorter with DCA even if 
overall time is lower with RAC  
 
 
Conclusions: For a single lesion, DCA provide better plan considering 
low doses to healthy brain even if quality indexes are better for the 
others techniques. For multiple lesions, RANC seems to be the best 
solution because it is able to deliver a good conformity and 
homogeneity plan while sparing healthy brain tissue. For a single 
lesion close to organs at risk, results are better with RAC at the cost of 
an increase of MU but a lower treatment time compare with RANC.  
 
 POSTER DISCUSSION: 14: CLINICAL: GYNAECOLOGY/ 
GASTROINTESTINAL 
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Purpose/Objective: To investigate the impact of bone marrow (BM) 
radiation dose on standardized uptake value (SUV) changes of 
18Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) 
taken pre and after chemo-radiotherapy in patients with cervical 
cancer, and to study the correlation between uptake values and 
acute/late hematological toxicity, respectively. 
S234  2nd ESTRO Forum 2013	
Materials and Methods: We evaluated 22 women diagnosed with 
cervical cancer that had undergone pre and post treatment FDG-PET. 
Patients were treated with standard doses of concomitant chemo-
radiotherapy in our department from 2005-2012. Using deformable 
image registration and dose remapping technology (Velocity AI 
software), we delineated total (BMtot) and active BM (BMact) volumes 
receiving >1 Gy on the radiotherapy planning image sets, combining 
dose matrix data of treatment planning and PET images. Minimum, 
mean, and maximum SUVs and dose maximum (Dmax), mean, volume 
receiving 10 Gy (V10), V20, V30, V40 were computed on BMtot and 
BMact separately using initial and after treatment (response) PET’s, 
respectively. Hemograms before the treatment start, during the acute 
toxicity period (nadirs), 3 months after the treatment (response PET), 
and at the late follow-up period were obtained. 
Results: Mean volumetric BMact/BMtot ratio was 45.6%. In two-tailed 
Student’s t-Test, initial /response SUV rates were 73% and 60% for 
BMtot and BMact, respectively; with significant reduction (p < 0.001). 
In two-tailed sign test, all dosimetric parameters of BMtot and BMact 
were different (p < 0.001) except Dmax. Significant correlations were 
observed in pairwise analysis between inital SUV values and acute 
hematologic nadirs; response SUV measurements and response PET 
hematological values, respectively (p < 0.05). Effects of varied 
parameters were found on acute and response PET hemograms in 
multiple logistic regression analysis but not on the hemograms of the 
last follow-ups. 
Conclusions: Our novel method to delineate and measure active bone 
marrow in radiation oncology combining deformable registration, 
metabolic imaging, and dose remapping can allow creating new 
models to predict both acute and late toxicity. Further analysis of this 
approach will be done with a larger cohort.  
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Purpose/Objective: To evaluate the patterns of nodal failure 
(recurrences and persistent disease) in patients with locally advanced 
cervix cancer. 
Materials and Methods: EMBRACE is a multicenter prospective 
observational study to investigate the impact of MRI guided 3D 
brachytherapy on outcome in locally advanced cervix cancer. 
Treatment consists of a combination of external beam radiotherapy 
(EBRT), MRI guided brachytherapy and concomitant chemotherapy. 
According to the protocol all elective pelvic nodal regions are treated 
with 45-50 Gy EBRT and macroscopic pathological nodes are boosted 
to about 60 Gy. Elective para-aortic irradiation to L1-L2 is given if 
pathological nodes are found at the level of common iliac or higher. 
This study includes 493 consecutive patients FIGO stage IB to IVB (with 
nodal involvement up to L2), included from November 2008 till July 
2011 with a median follow-up of 14 months. Cox regression analysis 
was performed comparing patients with and without nodal 
recurrences.  
Results: Lymph node involvement at time of diagnosis was present in 
235 patients (50%). 215 patients (46%) had suspicious nodes in the 
lower iliac (external/internal iliac), 70 patients (15%) in the common 
iliac and 39 patients (8.4%) in the para-aortic region. The highest level 
of verification was radiology in 38%, PET-CT in 35% and pathology in 
27%. The 2-year actuarial rate for nodal failure was 11%. Nodal failure 
occurred in 56 patients, 7 of which had persistent nodal disease, with 
median time to detection being 9 months (range 1-34 months). More 
than one lymph node region was involved in 45% of the patients. Nodal 
failures were present in 15% of node positive patients and 8% of node 
negative patients. Most nodal failures were located in the para-aortic 
region (n=35, 62%), with 77% of them being outside the radiation 
fields. Nodal failures in the lower iliac and the common iliac region 
occurred in respectively 39% (n=22) and 27% (n=15), all of which inside 
the elective treatment fields. In multivariate analysis the only 
predictive factors for nodal failure were tumour diameter ≥ 5 cm 
(p=.03) and presence of lymph nodes at time of diagnosis (especially if 
PET-CT positive or pathologically proven) (p=.003).  
 
  
Conclusions: Suspicious or proven nodal disease at time of diagnosis 
was seen in 50% of the patients with locally advanced cervix cancer. 
Tumour diameter ≥ 5 cm and nodal disease at time of diagnosis were 
predictive factors for nodal failure. Nodal disease at time of diagnosis 
was located mostly in the lower iliac, whereas nodal failures were 
located mostly in the para-aortic region. The majority of para-aortic 
recurrences occurred outside the radiation field, suggesting a deficit 
in treated volume due to suboptimal detection of clinical disease. 
Future work will focus on improved detection of nodal disease at time 
of diagnosis and on a more detailed analysis of dose volume effects 
with longer FU. 
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Purpose/Objective: Whole-pelvis concurrent chemoradiation (WP-
CCRT) is the standard treatment option for patients with locally 
advanced cervical cancer. However WP-CCRT could not decrease the 
para-aortic nodal recurrences, so our aim was to evaluate whether 
extended field concurrent chemoradiation (EF-CCRT) leads to results 
better to those obtained by standard WP-CCRT in locally advanced 
cervical cancer with radiologic negative para-aortic lymph nodes 
(PALN). 
Materials and Methods: Patient eligibility included histopathologically 
proven squamous cell carcinoma, adenocarcinoma or adeno-squamous 
cell carcinoma; radiologic negative PALN locally advanced cervical 
cancer stages IIB-IVA with normal hematologic, renal,and liver 
functions. Between July 2007 and April 2008, 82 were 
accrued.Patients were randomly assigned to WP-CCRT (40 patients) 
